Toll Free: 1-888-928-9744

ArQule, Inc. - Product Pipeline Review - 2015

Published: May, 2015 | Pages: 45 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

ArQule, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct's, 'ArQule, Inc. - Product Pipeline Review - 2015', provides an overview of the ArQule, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of ArQule, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of ArQule, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of ArQule, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the ArQule, Inc.'s pipeline products

Reasons to buy

- Evaluate ArQule, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of ArQule, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the ArQule, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of ArQule, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of ArQule, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
- Explore the dormant and discontinued projects of ArQule, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 ArQule, Inc. Snapshot 5 ArQule, Inc. Overview 5 Key Information 5 Key Facts 5 ArQule, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 ArQule, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 ArQule, Inc. - Pipeline Products Glance 10 ArQule, Inc. - Late Stage Pipeline Products 10 Phase III Products/Combination Treatment Modalities 10 ArQule, Inc. - Clinical Stage Pipeline Products 11 Phase II Products/Combination Treatment Modalities 11 Phase I Products/Combination Treatment Modalities 12 ArQule, Inc. - Early Stage Pipeline Products 13 Preclinical Products/Combination Treatment Modalities 13 Discovery Products/Combination Treatment Modalities 14 ArQule, Inc. - Drug Profiles 15 tivantinib 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 ARQ-087 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 ARQ-092 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 ARQ-761 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 ARQ-751 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Small Molecules to Inhibit BTK for Cancer 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Small Molecules to Inhibit S6K for Cancer 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Small Molecules to Inhibit Kinase for Oncology 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 ArQule, Inc. - Pipeline Analysis 25 ArQule, Inc. - Pipeline Products by Target 25 ArQule, Inc. - Pipeline Products by Route of Administration 27 ArQule, Inc. - Pipeline Products by Molecule Type 28 ArQule, Inc. - Pipeline Products by Mechanism of Action 29 ArQule, Inc. - Recent Pipeline Updates 30 ArQule, Inc. - Dormant Projects 35 ArQule, Inc. - Discontinued Pipeline Products 36 Discontinued Pipeline Product Profiles 36 ARQ-171 36 tivantinib 36 ArQule, Inc. - Company Statement 37 ArQule, Inc. - Locations And Subsidiaries 43 Head Office 43 Appendix 44 Methodology 44 Coverage 44 Secondary Research 44 Primary Research 44 Expert Panel Validation 44 Contact Us 44 Disclaimer 45
List of Tables
ArQule, Inc., Key Information 5 ArQule, Inc., Key Facts 5 ArQule, Inc. - Pipeline by Indication, 2015 7 ArQule, Inc. - Pipeline by Stage of Development, 2015 8 ArQule, Inc. - Monotherapy Products in Pipeline, 2015 9 ArQule, Inc. - Phase III, 2015 10 ArQule, Inc. - Phase II, 2015 11 ArQule, Inc. - Phase I, 2015 12 ArQule, Inc. - Preclinical, 2015 13 ArQule, Inc. - Discovery, 2015 14 ArQule, Inc. - Pipeline by Target, 2015 26 ArQule, Inc. - Pipeline by Route of Administration, 2015 27 ArQule, Inc. - Pipeline by Molecule Type, 2015 28 ArQule, Inc. - Pipeline Products by Mechanism of Action, 2015 29 ArQule, Inc. - Recent Pipeline Updates, 2015 30 ArQule, Inc. - Dormant Developmental Projects,2015 35 ArQule, Inc. - Discontinued Pipeline Products, 2015 36



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify